Olema Pharmaceuticals (OLMA) Equity Ratio (2020 - 2026)

Olema Pharmaceuticals (OLMA) has 7 years of Equity Ratio data on file, last reported at 0.91 in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.91, down 3.27% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.91 (down 3.27% YoY), and the FY2025 annual result was 0.9, down 1.07% from the prior year.
• Equity Ratio climbed to 0.91 in Q1 2026 per OLMA's latest filing, from 0.9 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.96 in Q1 2022 and troughed at 0.86 in Q3 2024.
• A 5-year average of 0.91 and a median of 0.91 in 2024 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2024 and 2025: Equity Ratio decreased 8.03% in 2024, then rose 4.45% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.92 in 2022, then advanced by 0.08% to 0.92 in 2023, then slipped by 1.08% to 0.91 in 2024, then declined by 1.07% to 0.9 in 2025, then grew by 0.93% to 0.91 in 2026.
• Business Quant data shows OLMA's Equity Ratio at 0.91 in Q1 2026, 0.9 in Q4 2025, and 0.87 in Q3 2025.